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ABSTRACT
Using Bayesian networks to identify control topography between cancer processes and immune
responses via metagene constructs.

Cancer arises from a deregulation of both intracellular and intercellular control systems.
Understanding the architecture of these control systems and how they are changed in diseases
could present opportunities for therapeutic targets to restore normal control. However, since
intercellular control structures only appear in intact systems, it is difficult to identify how these
control structures become altered using in vitro models and it can be difficult to determine if an
in vivo model system appropriately replicates what occurs in human disease. In order to
overcome this, we use the diversity in normal and malignant human tissue samples from the
Cancer Genome Atlas database of human breast cancer to identify intercellular control topology
in vivo. To improve the underlying biological signals from the noisy gene expression data, we
constructed Bayesian networks using metagene constructs, which represented groups of genes
that are concomitantly reported with different immune and cancer states. From these directional,
acyclic graphs, we found opposing relationships between cell proliferation and epithelial-tomesenchymal transformation (EMT) with regards to macrophage polarization. Furthermore, we
also found that it was possible to identify the relationship between EMT and macrophage
polarization with fewer datasets when the Bayesian network was generated from malignant
samples alone, while it was possible to identify the relationship between proliferation and
macrophage polarization with fewer samples when the samples were taken from a combination
of the normal and malignant samples. When the same technique was applied to other cancers,
we found a common result that proliferation was associated with a type 1 cell-mediated antitumor immunity and EMT was associated with a pro-tumor anti-inflammatory response. All
together, these networks give us an understanding of what relationships are occurring in human
cancer progression, and this knowledge can be used to help identify model system that more
closely mimic human disease progression.
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1

Introduction
Homeostasis is a basic requirement for life, and can be observed existing at many levels

in multi-cellular organisms, including at the cellular level (such as ion pumps maintaining an ion
gradient between the cell and its environment), at the tissue level (such as angiogenesis as a
means to maintain oxygen and nutrient delivery)1, and at the organism level (such as by
maintaining the internal temperature of the body). Tumorogenesis, in many ways, represents a
rewiring of and subversion of normal cellular circuitry resulting in an alteration of the normal
dynamic processes that would act to maintain homeostasis in the tissue microenvironment2,3.
These subversions can be rewiring that occur entirely within the cancer cell (such as achieving
replicative immortality and conversion of cells to more invasive phenotypes) or can include
alterations that change the tissue in which the cancer cells are growing (such as promotion of
angiogenesis)3.
A key aspect to understanding tumor progression is to understand that a tumor is
governed by the same evolutionary principles that control all life. While the idea that
evolutionary principles can be applied to tumorogenesis is not a new one4,5, it is becoming more
evident that cancer needs to be viewed as a evolutionary, dynamic process. However, it should
be noted that cancer growth represents somatic and not Darwinian evolution. This distinction
has several implications for how a cancer can evolve. First, since the evolution is occurring in
the somatic cells, individual mutations can be passed down to subsequent cancer cells, giving
rise to a heterogeneous population of cells. These mutations, while random and normally
negative for the cell, are selected by the same evolutionary forces that act on any organism (can
it acquire resources, avoid predation, and replicate itself)3. Somatic evolution also has
implications with regards to the time scale at which this evolutionary selection is taking place –
1

we have evolved methods to combat cancer on a generational timescale, whereas the tumor
evolves in a single individual. As such, the person is effectively static from the view of the
cancer. This, along with the fact that malignant cells begin as normal somatic cells, gives the
tumor the potential to not just adapt to its environment, but to adapt the environment to its own
needs6. This combination of normal evolutionary forces along with the ability of the cancer to
manipulate its environment drives cancer progression and helps give rise to hallmarks of cancer.
For example, it has been shown, both in biological and computational models, that unequal
nutrient distributions within an environment would select for more mobile forms of cancer7–10.
We have known about some of these alterations for a while, though a lot of the earlier research
focused on how the tumor manipulated itself for survival, as can be seen by the original
hallmarks of cancer, which focused almost entirely on intracellular alterations required for
cancer progression.11. This can be contrasted to the new enabling and emerging hallmarks,
which lists certain forms of inflammation as an enabler of tumor progression (sometimes through
increased genetic damage, and also through predation of certain forms of cancer3,12,13), and
eventual escape of the immune system as a hallmark of cancer (either through a change in the
cancer itself to make itself less immunogenic14,15, or by biasing the immune system to an
unproductive response16).
Identification of these changes in control remains a challenge. Part of the difficulty is
due to current laboratory techniques. Most cell based techniques were developed as a means to
observe and manipulate processes within a cell, and while some of these techniques can be
modified to observe certain interaction between cells – such as through co-cultures17 - they are
mostly limited to identifying intercellular phenomena. Furthermore, this analysis requires an a
prior assumption about which cells and environmental conditions are needed in order to observe
2

the physiologically significant relationships, and while it does make it possible to determine what
events are occurring within the culture, it does not offer a means to verify if these interactions are
biologically relevant. Finally, most conventional experimental designs are fairly focused, and
require the assumption that you are already looking for the relevant interactions. More
complicated interactions can be observed by the use of in vivo models, such as through
xenografts, the use of established cancer cell lines, or the use of genetically engineered mice
(GEM). Xenografts, while they can use human cancers that have arisen naturally and can be
useful for general observation of human cancers, are not ideal when trying to identify
interactions between the tumor and the host, as the species gap can mask the interactions, and
there is no guarantee that the same processes are relevant in both species18. Use of an established
mouse cancer cell line or GEM mice gets around the species problem, but results in studying the
a mouse disease in mice, which, even if they contain the conserved genes and proteins, may
result in a fundamentally different response when the same phenomenon is viewed in
humans19,20.
These problems affect more than just cancer research, and as high throughput sample
processing is becoming more cost efficient, along with the subsequent increases in available
genetic, mRNA, and protein expression data available, people are turning more towards a
systems view of disease21. One source of data that can be used to identify such interactions is
analysis of human cancer biopsy data. These tissue samples contain malignant cells and
infiltrating immune cells, which enables insight into the nature of the local immune response that
is occurring with the tumor. It is also biologically relevant, as it is using human data, and since it
comprises multiple cell types, it can be used to help generate an influence diagram that would
help in observing the overall control mechanisms.
3

Along with the advent of high throughput data is the potential to utilize probabilistic
inference methods to identify relationships out of the data that could not be observed using
simpler statistical techniques22. One of the methods that can be used to identify the topology of
an in influence diagram in an unbiased method is through the use of algorithms that identify
Bayesian networks21. Bayesian networks are a type of directed acyclic graphs (DAG), where
each node represents a random variable and each edge represents a causal relationship between
two nodes. Bayesian networks have previously been used to model signaling pathways within
cells23, correctly identifying the known DNA repair networks in E. coli using microarray data24
and simple phosphorylation cascades in T lymphocytes using flow cytometry data25,26. The use
of Bayesian networks with flow cytometry data is particularly powerful, as it allows each cell to
viewed as an individual event, and possible extreme cases, which are useful in identifying
Bayesian networks, are not lost through averaging25.
At the same time, there are limitations to using flow cytometry data when trying to
construct a Bayesian network. For example, analyzing cells via flow cytometry severely limits
the amount of proteins that can be observed at a single time26, which proves to be a significant
limitation when trying to understand networks that involve potentially hundreds of genes and
proteins. Furthermore, most studies thus far have focused on identifying intracellular events that
occur over a relatively short timeframe – on the order of minutes or hours. Our objective is to
identify long term changes that occur in conjunction with disease progression - a process that
occurs over months or years and that is reflected in changes in cell populations within a tissue
and cellular development processes. In particular, we are looking at the interplay of processes
that are commonly associated with oncogenesis and immune surveillance. Microarray data, on
the other hand, loses some of the diversity found in flow cytometry data, but if obtained from a
4

complex sample can provide insight into cellular composition within a tissue. It is limited,
though, by the computational expense associated with identifying a Bayesian network. While
Bayesian networks can handle noisy data, which microarray data normally is, the time required
to generate the network increases greatly as the number of nodes increases27. Given our study
objective and the limitations of computational methods, we combined Bayesian network analysis
with metagene constructs to identify relationships between oncogenic processes and immune
surveillance.
The purpose of this study is to see if we can identify causal evidence of crosstalk between
events associated with local cellular immune-surveillance during breast cancer oncogenesis
given pre-existing microarray data, metagene constructs, and Bayesian networking. In short, we
found that cellular proliferation and EMT had opposing relationships with macrophage
polarization in invasive breast cancer, with increased proliferation being associated with
classically activated macrophages (M1) and EMT being associated with alternatively activated
macrophages (M2). We found that sample size and complexity affected the resulting Bayesian
networks, with smaller sample sizes resulting in less complex networks, while changes in the
composition of the sample influenced the relationships that were seen. When we expanded this
study to other forms of cancer, we saw that overall increases in proliferation went along with
increases in cell mediated anti-tumor immunity whereas increases in EMT resulted in decreases
in cell mediated anti-tumor immunity.

5

2

Methods

2.1 Data Acquisition
Gene expression values in normal and malignant tissues were obtained as part of the Cancer
Genome Atlas (TCGA)28. In short, homogenized samples taken from primary tumors after
diagnosis but before treatment or from matched normal tissue samples were analyzed using on
the Agilent G4502A 07 microarray chip. Gene expression was determined, and genes were
normalized to a log2 scale using the RMA (Robust Multichip Average) method29, with negative
numbers representing lower gene expression and positive numbers representing greater gene
expression. Level 3 tissue microarray data were downloaded for the invasive breast carcinoma
samples (BC, tumors = 599, normals = 65), glioblastoma multiform (GBM, tumors = 482,
normals = 10), lung squamous cell carcinoma (LUSC, tumors = 155, normals = 0), and colon
adenocarcinoma (COAD, tumors = 174, normals = 9) samples. In this case, normals represent
microarray data from normal, non-cancerous tissue. Genes of interest were identified, and
samples missing any of the genes were eliminated from the study.
2.2 Metagene calculations
To represent cellular processes, we used metagene constructs. A metagene is the expression and
aggregation of individual genes observed by microarray data, and can represent either cell
infiltration, cell polarization, or a cellular process. Each metagene is defined a priori by genes
that are either known to be uniquely upregulated or downregulated during a cellular process or
during cell differentiation. These metagene constructs serve two purposes in this study. First, it
simplifies the data, bringing it together in such a way that it can more easily understood. A DAG
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Table 1: Gene list of Metagenes

Metagene

Genes

Ref.
#

Proliferation

DNMT3B, MCM6, CDC25A, PFAS, MCM4, XRCC5, FAM29A, CXXC6, IGF2BP1,
PLAA, DEPDC1B, TEX10, CCDC99, MSH6, DLG7, SKIV2L2, CENPE, CHEK2,
SOHLH2, CCNB1, RRAS2, PRIM1, PAICS, CCNA2, CPSF3, NUSAP1, LIN28B,
IMP5, KIF11, BMPR1A NDC80, BCAT1, CCNG1, ASCC3, FANCB, MCM10,
HMGA2, SKP2, TRIM24, ORC1L, HDAC2, HESX1, C1orf45, INHBE, C21orf45,
DCUN1D5, POLE2, MRPL3, CENPH, MYCN, CCDC5, GDF3, TBCE, RIOK2,
BCKDHB, RAD1, C5orf13, ADH5, PLRG1, ROR1, RAB3B, DBC1, KIF23, DIAPH3,
GNL2, FGF2, TARDBP, NMNAT2, ZNF167, KIF20A, CENPI, DDX1, C3orf21,
GPR176, FBXO22, BBS9, C14orf166, FAM44B, CDC123, SNRPD3, FAM118B,
PDH3, EIF2B3, KDELC1, APLP1, DACT1, PDHB, C14orf119, DTD1, SAMM50,
CCL26, CCDC9-B, MED20, UTP6, RARS2, KIAA0020, ARMCX2, RARS,
MTHFD2, DHX15, HTR7, HIST1H4C, MTHFD1L, ARMC9, XPOT, IARS, HDX,
ARPM1, ERCC2, GARS, KIF7, HIP2, SLC25A3, ICMT, UGCGL2, ATP11C,
SLC24A1, EIF2AKA, ALX1, DC2, TRPC4, HAS2, FZD2, TRNT1, SNX8, CDH6,
HAT1, SEC11A, DIMT1L, TM2D2, FST, GBE1
SNAII2, COL5A2, FAP, POSTN, COL1A1, COL3A1, FBN1, TNFAIP6, MMP2,
GREM1, BGN, CDH11, SPOCK1, DCN, COPZ2, THY1, PLOCE, PRRX1, PDGFRB,
SPARC, INHBA, COL6A3, FN1, ACTA2, COL11A1, THBS2, COL10A1, COL5A2,
LRRC15, COL5A1, MMP11, ADAM12, LOX, AEBP1, SULF1, ASPN, CTSK, HNT,
EPYC, PLAU, OLFML2B, LUM, LOXL2, MXRA5, MFAP5, NUAK1, RAB31,
TIMP3, CRISPLD2, ITGBL1, TMEM158, SFRP4, SERPINF1, C7orf10, NOX4,
EDNRA, RCN3, C1QTNF3, COMP, LGALS1, COL6A2, GLT8D2, NID2, AXIN2,
PITX2, MITF, NRCAM, TCF4, LGR5, FST, LEF1, FN1, FGF4, MMP7, RHOU,
CLDN1, FGF18, MYC, MYCBP, JUN, FZD7, PPARD, WISP1, CTLA4, TNFRSF19,
EN2, SP5, HNF1A, FOSL1, STRA6, VEGFA, ID2, WNT1, WNT10A, WNT10B,
WNT11, WNT16, WNT2, WNT2B, WNT3, WNT3A, WNT4, WNT5A, WNT5B,
WNT6, WNT7A, WNT7B, WNT8A, WNT8B, WNT9A, WNT9B
CD247, CD3D, CDD3E, CD3G, ITGAL, ITGB2, ICAM1, CD2, CD28, THY1,
PTPRC
KLRC1, KLRC2, KLRC3, KLRD1

30

35

Th1

CD14, MRC1, CPM, ITGAM, NOS2, HLA.DRA, HLA.DMA, HLA.DOA,
HLA.DPA1, HLA.DQA1, HLA.DQA2
CD4, IFNG, IL10, FASLG, EOMES, TBX21

Th2

CD4, IL4, IL5, IL10, GATA3

36

Th17

CD4, IL17A, IL17F, RORA, RORC

36

Treg

CD4, TGFB1, IL10, IL12A, EBI3, RORC, FOXP3, TBX21, CCR6, MYB

36

Macrophage
1
Macrophage
2

IDO1, IL23A, IL12B, CCL17, IL1B

35

ARG1, TIMP2, LYVE1, KLF4, CD163, STAB1

35

EMT

T-cell
Natural
Killer Cells
Macrophages

31,32

33

34

36
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containing fourteen nodes is much easier to make sense of then a DAG containing nearly three
hundred nodes and is much more computationally traceable27. The reduced computational
expense enables one to test hypothesis related to network topology via simulations, for instance,
the statistically significance of an edge can be obtained by comparing how often an edge is
inferred from the TCGA data relative to a dataset that has no information – that is, a null
hypothesis. Secondly, it serves as a means of helping to eliminate error. Microarray data is
noisy, with the result given being the summation of both the true gene expression as well the
noise inherit to the assay (i.e., lab variability, experimenter skill, sensitivity of the machine, and
batch of reagents used)24. The metagene helps eliminate this error as it averages across several
genes. The genes that make up each metagene are identified in Table 1.
The presence of T cells, Natural Killer cells, and macrophages in the tumor microenvironment
were represented by immune infiltrate metagenes33. The value for an immune infiltrate
metagene were calculated according to the formula:
𝑛

𝑣 = ∑ 𝑦𝑗 /𝑛
𝑗=1

where n represents the number of genes in the metagene and 𝑦𝑗 equals the expression of gene j
in the metagene.
The EMT31,32 and proliferation30 metagenes were calculated according to the formula:

𝑣=

𝑛
∑𝑛𝑗=1((𝑦𝑗 − (𝑦̅𝑗 + 3𝜎𝑗 ))/(𝜎𝑗 ))2 ,
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where n represents the number of genes in the metagene, 𝑦𝑗 equals the gene expression of the jth
gene in the metagene, 𝑦̅𝑗 represents the mean of gene 𝑦’s expression in the dataset and 𝜎𝑗 equals
the standard deviation of the gene.
Polarization of T cells into one of four subsets and of macrophages into one of two subsets35,36
were calculated according to the equations below
𝑛

𝑣𝑖 = ∏(𝜎𝑗 /(𝑦𝑗 − (𝑦̅𝑗 ± 3𝜎𝑗 )))2 ,
𝑗=1

𝑃(𝑀𝑖 |𝑌) =

𝑣𝑖

∑𝑚
𝑘= 1 𝑣𝑘

,

where 𝑦𝑗 equals the gene expression of the jth gene in the metagene, 𝑦̅𝑗 represents the mean of
gene 𝑦’s expression in the dataset and 𝜎𝑦 equals the standard deviation of the gene. The
standard deviation is either added or subtracted from the mean depending on whether the gene is
upregulated or down regulated in the polarization, with upregulated genes being added and down
regulated genes being subtracted. 𝑃(𝑀𝑖 |𝑌) is the probablilty of polarization state 𝑖 given the data
Y, and 𝑚 represents the total number of possible polarizations. Products were used as we
assumed the expression of the genes to be mutually inclusive, with a polarization only being
considered when all of the genes for it were upregulated when compared to the gene expression
of the alternative polarizations. All calculations were performed in R37.

9

2.3 Bayesian Networks
Bayesian networks were generated from the metagene data using an Incremental Associated
Markov Blanket (IAMB) as described by Tsamardinos38 and implemented in R. In short, IAMB
is made up of two phases – a forward stage where a network is generated in such a way that it
maximizes the conditional independence of the nodes, and a backwards phase where it is
removes any remaining conditionally independent connections. This results in the construction of
a Markov blanket. A Markov blanket of a node is defined as the set of other nodes that contains
all the information in the data set that can aid in predicting the value of the node of interest. A
simple way to think of a Markov blanket is to take a set that contains all of the nodes that are
related to the node of interest, then remove any nodes from that set that are conditionally
independent, and add in any nodes that are conditionally dependent. Conditional independence
is the situation where two variables that are partially dependent on each other when viewed in
isolation become independent when combined with a third variable. This can be explained using
a simple example – the genetic information of a child, their father, and their paternal
grandmother. The genome of the child is correlated with that of their grandmother (as would be
expected, 1/4th of their genes came from the paternal grandmother). However, the child is
conditionally independent of their paternal grandmother if we know the genome of the father –
since any genetic information shared between the grandmother and the child would need to go
through the father, nothing more can be inferred about the child’s genome knowing both the
father’s and paternal grandmother’s genome than can be inferred if you know just the fathers
genome. Note that the reverse is not true – a child is not conditionally independent of their
parent given the grandparent, we can still infer more about the child’s genome. In a sense,
identification of conditional independence allows for the identification of intermediates – the
10

genetic information of the paternal grandmother was transported to the child through the father.
Another concept that goes along with conditional independence is conditional dependence –
where two variables that are independent of each other when observed in isolation become
dependent with the addition of a third variable. To carry the example from earlier further, the
genome of the mother is independent of the genome of the father, meaning you can’t infer
anything about the mother’s genome by knowing the father’s genome. However, the two
genomes become dependent if the child’s genome is known – you can infer more about the
mother’s genome if you know the genome of both the child and the father than if you knew the
genome of just the child. Thus, the Markov blanket for the father includes the father’s parents,
his child, and his wife, but would not include the father’s grandparents, siblings, or
grandchildren. It should also be noted that reversed networks are functionally equivalent. This
distinction is important when it comes trying to define causal relationships; while from a
Bayesian network standpoint a → b → c is functionally the same as c → b → a, it does not make
sense to say that a child’s genome influences their father’s genome, which in turn influences the
grandparent’s genome39. To get around this limitation, one of two things must be done: first, one
of the directional relationships needs to be defined a priori or second, the dataset used to
generate the network needs to include temporal data40.
Confidence for the node edges was calculated using a bootstrap resampling method that
included 100,000 replications39. For each replicate, patient data was randomly sampled with
replacement n times, where n is the starting number of patients in the dataset, and a network was
generated from the new dataset. Lines were only included if they had a p-value of less than 0.01.
Bayesian networks were generated for all cancer sets. To assess how the complexity of the
TCGA study samples influenced network generation, we also generated networks for smaller
11

subsets of in data, including the tumor samples only or a percentage of the entire dataset (75%,
50%, 25%). These percentage subsets were generated by sampling without replacement from the
entire cohort. Model generation and averaging were performed in R using the boot.strength()
and the average.network() methods from the bnlearn package. Since temporal data from a single
patient was not available, we used matched normals and various patients to simulate temporal
data. We assume these cross-sectional samples from normal and diseased tissue represents
random samples from a common temporal trajectory associated with oncogenesis.
2.4 Statistics
Expression data for only the genes of interest were analyzed in R, and heatmaps were generated
using the heatmap.2() function. Patients and genes were clustered using the ward method.
Principal component analysis was performed on the data using the prcomp() function, with scale
set to false, and rotational data for the genes were returned. Differences in node connectivity
and average Markov blanket size were compared using two way ANOVA’s. Distributions
between cancer group 1 and cancer group 2 were compared using the Mann-Whitney-Wilcoxon
test. P-values for the Mann-Whitney-Wilcoxon test that were less than 0.01 were considered to
be statistically significant.
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3

Results

3.1

Identification of patient subtypes and metagenes
While the genes we used to identify the different metagenes were identified and created

using human data, we wanted to verify their usefulness, both in their use to distinguish between
patients, and also to see if they did, in fact, vary together. To see if the genes selected could
distinguish cancer and non-cancer patients, hierarchical clustering was performed on the genes
used in the metagenes (fig. 1), and the patients were divided into three groups. The patients,
with a couple of exceptions, divided into three groups, one normal group and two cancer groups.
This suggests that the patients, at least, can be separated by the genes chosen for the metagenes,
with normal samples being separated from the tumor samples, and the tumor samples being split
into two groups, one of which more closely resembles the normal samples.
In order to better understand how the different metagenes explained the variance samples
observed, Principal Component Analysis was performed. It was found that a large percentage of
the variance was explained in the first four principal components (fig. 2a, 54%), and that the
genes associated with EMT and proliferation were separated by principal component 1 (fig. 2b –
fig 2d). This can be observed by looking at the distribution of the genes, with most of the
proliferation metagenes grouping towards the far right on PC1, whereas the EMT genes tended
towards the center and left portions. This also means that since the behavior of 256 genes can be
simplified to 4 dimensions, that many of the genes are varying consistently with each other. It
should be noted that there are several genes that cluster near the origin in all 4 principal
components – these genes could potentially be removed, as they are uninformative with regards
to the breast cancer, but were not excluded in this case as they could be informative in other
cancers.
13

Cancer or Normal
Grouping

Figure 1: Hierarchical clustering of breast cancer patient data separates the patients into cancer
and non-cancer patients. Hierarchical clustering of the patient gene signatures separate the patients
into three groups, two cancer groups and one normal group. Hierarchal clustering was performed
on patient data for the genes listed in Table 1. Patients were colored based on whether the sample
came from normal breast tissue (blue) or tumor breast tissue (red) and were grouped into three
groups, group 1 (black), group 2 (purple), and group 3 (green). Genes were color coded based on
metagene grouping, EMT (black), Proliferation (grey), T cell infiltration (green), NK cell
infiltration (red), Macrophage Infiltration (orange), T cell polarization (yellow), and Macrophage
polarization (blue)
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Since both of these metagenes informed principal component 1, we looked to see how the
distribution of these metagenes differed between the two cancer groups and the normals. As
would be expected, it was found that expression of the proliferation metagene was increased in
both cancer group 1 and cancer group 2 when compared to the normal group, although the two
cancer groups did not have identical distributions (fig. 3b). However, it was observed that
expression of the EMT metagene was increased primarily in cancer group 1, with cancer group 2
and the normal group having a very similar distribution (fig. 3a). Similar to the group
differences in proliferation the macrophage polarization was very different between the cancer
and normal patients, with the cancer patients exhibiting a shift from the M2 to the M1
polarization, with group 2 exhibiting a much stronger bias(fig 3c). This is of interest, as both
polarization play different and opposite roles in cancer immunology. This is not surprising, as
the M1 macrophage, also known as the classically activated macrophage, is activated via
inflammation while the M2 mostly plays a role in wound healing. As such, the two cancer
metagenes can mostly separate the patients into the three groups found in the hierarchical
clustering - at least in regards to explaining the overall variance seen in the gene expression with the proliferation metagene primarily showing whether the biopsy came from a normal or
tumor, and the EMT metagene seemingly mostly distinguishing between different cancers. Due
to the role that EMT plays in invasiveness41, however we could not identify a relationship
between EMT expression and existing distal metastasis. This may be due to the fact there was a
very low number of patients who had metastasized (n = 8, Supplemetal Table 8).
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Figure 2: Most of the variability in the gene data can be captured in the first four principal

+components. Principal component analysis was performed on the data from fig.1, and the amount of
variability explained by each component was graphed (a). Genes were color coded based on metagene
grouping, EMT (black), Proliferation (grey), T cell infiltration (green), NK cell infiltration (red),
Macrophage Infiltration (orange), T cell polarization (yellow), and Macrophage polarization (blue),
and a rotational graph representing the role of each gene in principal components 1, 2, 3, and 4 were
generated (b).
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Figure 3: The distribution of the EMT (a), the proliferation (b), and the M1 macrophage polarization (c)
were calculated and the group averages were displayed as a solid vertical line. Groupings were based on
figure 1, with black representing cancer group 1, purple representing cancer group 2, and green representing
normals.
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3.2

Use of Bayesian networking as a means to identify topology of extracellular control

networks
After confirming that the genes naturally cluster into the different metagenes, we asked
whether we could observe evidence of crosstalk between the cancer and immune metagenes. To
accomplish this, a Bayesian network of the metagenes was generated using an IAMB algorithm.
Although Bayesian networks can be used to identify causal relationships between data points,
causality can only be inferred if there is either temporal data, or the direction of the edges are
known a priori. Since we could not analyze multiple cancer biopsies from a single patient from
across time, we used the whole dataset along with the matched normals as a means to simulate
temporal disease progression40. The generated network represented the averaging of 100,000
generated networks, a process that had previously been shown to be a fairly conservative method
of identifying edges39. When the analysis was performed on the whole data set of invasive breast
cancer, it was observed that the EMT metagene and the proliferation metagene had reciprocal
effects on macrophage polarization, with EMT seemingly being associated with increases in
macrophage type 2 polarization (M2) and proliferation being associated with macrophage type 1
polarization (M1) (fig 4a). This is of interest, as macrophage polarizations are thought to play
opposing roles in cancer immunosurveillance. The M1 polarization is the classical macrophage,
which serves to scavenge cell debris and is generally pro-inflammatory42. In contrast, the M2
polarization is associated with wound healing, suppression of inflammation, and is considered to
promote tumor growth43,44. These relationships are captured in the generated network, with an
M1 polarization also being associated with an increase in overall T cell infiltration and M2 being
associated with a decrease in T cell infiltration. When the analysis was repeated using only gene
expression values derived from tumor samples of invasive breast cancer cohort, the relationships
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between EMT and macrophage polarization, as well as the relationship between macrophage
polarization and T cell infiltration persisted (fig 4b). However, the relationship between
macrophage polarization and proliferation was lost. This implies that the relationship between
macrophage polarization and proliferation was mostly informed by the change from normal to
cancer. It is also worth noting that not all relationships with proliferation were lost with the
change from using all samples to only using cancer samples. For instance, the relationship
between proliferation and the T helper Type 1 cells (Th1) polarization was maintained, and the
confidence was, in fact, increased (p-value = 1.45E-20 vs. p-value = 7.0E-15). This suggests that
the relationship between the Th1 polarization and proliferation is a relationship inherent to
invasive breast cancer, and not simply representing a change from normal to cancer.
Since EMT and proliferation played opposing roles in the Bayesian networks with
regards to macrophage polarization, we next wanted to see whether their overall distribution was
different in the two cancer groups. It was found that the two groups did differ significantly with
regards to their average EMT metagene expression, with group 1 having a higher average
expression (p value < 0.001, Mann-Whitney Wilcox, Supplemental Figure 1i). Surprisingly,
though the means were much closer together, the difference between the two groups in the
average proliferation metagene expression was statistically significant, with group 2 having a
higher expression (p value = 2.95e-7, Supplemental Figure 1j). As would be expected from the
Bayesian network, it was found that the two groups did differ significantly with regards to their
macrophage polarization, with group 2 having higher levels of M1 polarized macrophages (p
value = 9.40e-15, Supplemental Figure 1h). As would be expected with the changes in
macrophage polarization, group 1 also had a statistically significant increase in Th2 and Treg
polarizations, with Treg being anti-inflammatory and Th2 being commonly opposed to Th1, and
19

Figure 4: Bayesian networks reveal cross-talk among polarized immune subsets and inverse relationships
between the proliferation and EMT metagene with regards to macrophage polarization. Bayesian networks
were generated for BC data using either the whole data set (a) or just the cancer dataset (b). In both cases the
network was generated using an IAMB algorithm, with the network representing the average of 100,000
generated Bayesian networks. Black lines represent positive relationships while red lines represent negative
relationships. The line thickness is proportional to the negative log of the confidence in the connection, with
thicker lines representing a higher confidence. Confidence p values are given in the supplemental table 1.
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Th1 polarization being higher in group 2. These interactions, however, did not appear to be
direct effects as indicated by the Bayesian network inference results.
While the objective of using Bayesian network inference is to identify more complex
multivariate relationships within the dataset, we also wanted to see if the relationships between
cancer and immune metagenes could be observed directly. Since the whole data set was required
to observe both relationships, we looked to see if there was much of a direct correlation between
either the EMT metagene or the proliferation metagene and macrophage polarization. We found
a very weak but significant correlation between EMT and macrophage polarization (r = -.18, pvalue < .001, fig 5), while the correlation between proliferation and macrophage polarization was
a bit stronger (r = .34, p-value < .001, fig 5). This, however, is not too surprising. First, while
the proliferation and EMT metagenes exist as a continuum, the macrophage polarization
metagene is mostly binary. Secondly, the Bayesian network suggested that the interactions
between EMT and macrophage polarization was rather subtle, as shown by the larger p-value
when compared to the p-value for proliferation and macrophage polarization (p value of 5.07e-5
vs 7.38e-16), which can be considered as a strength of evidence.
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Figure 5: The relationships between EMT, Proliferation, and M1 Macrophage polarization show subtle
relationships between themselves. Below the parallel correlation graphs are shown for the three metagenes.
Black dots represent data from cancer group 1, purple dots show data from cancer group 2, and green shows data
from matched normals. Above the parallel is the correlation coefficient, size scaled to strength of relationship.
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3.3

The sample size and diversity of a data set influences network generation and

verification of metagene constructs
We next determined the overall effect of sample size and diversity of the TCGA dataset
with regards to the generated networks to assess how this approach could be generalized. To
accomplish this, we generated mock datasets that represented 75% (fig 6a), 50% (fig 6b), or 25%
(fig 6c) of the dataset by drawing randomly without replacement from the whole invasive breast
cancer data set. As one would expect, the network appeared to be become progressively less
complex as the dataset became smaller. It also appeared that the overall confidence levels
associated with the edges fell. Interestingly, when the dataset was reduced to 25%, the
relationship between EMT and macrophage polarization was lost, although the relationship
between proliferation and macrophage polarization endured. This is consistent with our findings
that the relationship between EMT and macrophage polarization was more subtle, and also
implies this relationship might not be identifiable with a smaller dataset.
The relationship between proliferation and macrophage polarization is interesting, as it
was lost with the removal of the normal breast tissue samples but persisted in the 75% and 50%
subsets. To better examine the impact of the inclusion of normal samples, we repeated the
experiment using only cancer samples (fig 7). In this case, the relationship between EMT and
macrophage polarization was maintained through all datasets. While the relationship between
proliferation and macrophage polarization was lost in all subsets, the relationship between
proliferation and Th1 polarization was also maintained. It is also interesting to note that these
datasets generated orphan nodes – nodes that contain no connections to any other. This suggests
that the inclusion of normal patient data was required for the identification of the relationship
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between proliferation and macrophage polarization. In contrast, the exclusion of normal patient
data made it easier to identify the relationship between EMT and macrophage polarization.
In order to get a better idea of the overall effects of changing the complexity and size of
the dataset used, 10 replicates of the earlier studies were performed, each containing 100,000
bootstrap samples, and the resulting complexity of the inferred networks was quantified by their
average node connectivity and Markov blanket size (table 2). In this particular case, the amount
of samples drawn from either dataset was equal to the percentage of cancer samples only, since
we wanted to directly compare the tumor only and tumor and normal datasets to each other
without the influence of overall difference in number between cancer and combined groups
influencing the network complexity. What we found was that average Markov blanket did not
change between using the entire dataset versus using cancer dataset only, though there was a
statistically significant difference in average Markov blanket size and node connectivity when
comparing the smallest dataset (25%) to the largest dataset (75%, p-value < .01). There was,
however, a decrease in node connectivity when the network was generated from cancer dataset
alone (p-value < .01).
One potential concern of the model that we are using is that while certain metagenes are
defined independently of each other (for example, immune cell infiltration, proliferation, and
EMT), other metagenes, such as immune polarization, are defined as mutually exclusive. For
instance, M1 macrophage polarization is defined both by the increased expression of M1
associated genes and by a decrease in M2 associated genes. To test our inference approach, we
tested whether the immune polarization networks were informed by the data or constrained by
the particular model formulations. In order to test this, we focused on the T helper cell
polarizations, and compared the connections generated from real data to the connections derived
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Figure 6: The relationship between EMT and macrophage polarization appears to be subtle, and is lost when the
network is generated from subsamples of the dataset. Bayesian networks were generated using random sampling
without replacement of the whole data set, with subsamples representing 75% (a), 50% (b), or 25% (c) of the
whole BC dataset. In all cases the network was generated using an IAMB algorithm, with the network
representing the average of 100,000 generated Bayesian networks. Black lines represent positive relationships
while red lines represent negative relationships. The line thickness is proportional to the log of the confidence in
the connection, with thicker lines representing a higher confidence. Confidence p values are given in the
supplemental tables 5, 6 and 7.

25

Figure 7: The relationship between EMT and macrophage polarization is maintained when subsamples
are taken of only the cancer samples. Bayesian networks were generated using random sampling without
replacement of the BC dataset containing only tumor biopsies, with subsamples representing 75% (a),
50% (b), or 25% (c) of the BC dataset. In all cases the network was generated using an IAMB algorithm,
with the network representing the average of 100,000 generated Bayesian networks. Black lines represent
positive relationships while red lines represent negative relationships. The line thickness is proportional
to the log of the confidence in the connection, with thicker lines representing a higher confidence.
Confidence p values are given in the supplemental tables 5, 6 and 7.
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from metagenes generated from random genes. To accomplish this, we scrambled the genes
associated with each polarization subset and repeated the analysis. What we found was a
redirection in relationships (specifically Th1 no longer having connections to T helper type 17
(Th17) and T helper type 2 cells) (fig 8). Furthermore, in the repeated analysis, there was an
ambiguity in the nature of the relationship between Th1 and Treg, with some models finding a
positive relationship while other networks identified a negative relationship. However, the
overall shape of the graph was consistent across all three gene reshufflings, which suggests that
the data plays at least some role in determining the final relationships. Furthermore, prior studies
had identified a reciprocal role for Th1 and Th17 in human tumor infiltrates45.

27

Table 2: Average connectivity and Markov blanket size of invasive breast cancer subsets
% of Dataset

Cancer Only,
Average node
connection **

Cancer + Normals,
Markov Blanket
Size

Cancer Only,
Markov Blanket
Size **

Whole Dataset

Cancer +
Normals,
Average node
connection
2.92

2.46

3.69

3.07

75% (n = 399)

2.95 ± 0.06

2.61 ± 0.10

3.67 ± 0.20

3.23± 0.17

50% (n = 266)

2.87 ± 0.13

2.43 ± 0.15

3.56± 0.18

3.21± 0.49

25%* (n = 133)

2.28 ± 0.12

2.15 ± 0.25

2.71± 0.25

2.84± 0.64

Mean and standard deviation of average node connections and Markov blanket size were calculated for the whole
invasive breast cancer dataset and cancer only invasive breast cancer dataset. Percentages were based on the size
of the cancer only datasets. 2-way ANOVA was performed on the data. * signifies a difference between that row
and the 75% row. ** signifies a difference between that column and the total data set
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Figure 8: The relationships between the T-cell polarizations are defined by the data, and not by the model.
The genes used to identify each T helper call subtype were replaced with random immune genes used in the
study, and the probability of the polarizations were recalculated. Bayesian networks were then generated using
an IAMB algorithm, with the network representing the average of 100,000 Bayesian networks generated from
resampling. This was replicated 6 times. A) represents networks from real data and B) represents data from
the random data. Black lines represent positive relationships while red lines represent negative relationships.
Dual arrows represent were both relationships were observed.
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3.4

Similar Bayesian networks are identified in other cancers
One of the advantages of using the TCGA study is that it spans many different cancers

and samples are processed similarly. This helps minimize variation in network inference that
may be introduced by study design. We wanted to determine if the relationships we observed
were specific to breast cancer, or if similar relationships could be observed in other cancers. In
order to do this, we downloaded complete datasets from the lung squamous cell carcinoma (fig
9a), colon adenocarcinoma (fig 9b), and glioblastoma multiform (fig 9c) arms of the TCGA
study. While glioblastoma technically is not a carcinoma, it had been reported that it does
undergo a shift towards a mesenchymal state, resulting in an increase in expression of EMT
genes46. Overall the generated Bayesian networks for the other cancers were similar but not
identical to the overall network inferred from the breast cancer dataset. For example, identical
relationships between proliferation and macrophage polarization were observed in the colon
adenocarcinoma and glioblastoma multiform datasets, but were not seen in the lung squamous
cell carcinoma dataset. In addition, the relationship between EMT and macrophage polarization
was observed only in the lung squamous cell carcinoma dataset. Differences in the Bayesian
networks were not unexpected, given the size and composition of the datasets (Table 3). For
example, the lung squamous cell carcinoma dataset, while small, only contains tumor biopsies,
and identified the least complex network. In contrast, the colon adenocarcinoma dataset is small
but contains a mixture of both normal and tumor biopsies and the inferred network has more
connection. The glioblastoma multiform network is interesting as it was the most complex and
contained more connection than the other cancer networks, but it also represents relationships
that, unlike all the other networks, arise in an immune privileged area47.
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Table 3: Node connectivity and Markov blanket size of all cancer data sets used in study.

Cancer

Average node
connectivity
2.77

Average Markov
Blanket Size
3.69

Number of
Tumor Samples
532

Number of
Normal Samples
65

Glioblastoma
Multiform

2.92

4.00

467

10

Lung Cancer

1.85

2.40

154

0

Colorectal Cancer

2.31

2.46

154

19

Breast Cancer

Values represent the mean node connectivity and Markov blanket size for the networks generated using the breast
cancer, glioblastoma multiform, lung cancer, and colorectal cancer datasets. The total numbers of tumor and
normal samples used in the analysis are also provided.
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Figure 9: Bayesian networks of other cancers. Bayesian networks were generated using the metagenes for the lung
cancer (a), colon adenocarcinoma (b), and glioblastoma multiform (c) datasets. In all cases the network was generated
using an IAMB algorithm, with the network representing the average of 100,000 generated Bayesian networks.
Black lines represent positive relationships while red lines represent negative relationships. The line thickness is
proportional to the log of the confidence in the connection, with thicker lines representing a higher confidence.
Confidence p values are given in the supplemental tables 2, 3 and 4.
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4

Discussion, conclusions, and recommendations
The purpose of this study was to identify evidence of alterations in the normal behavior

of the immune system that are causally related to oncogenic changes, namely an increase in
proliferation and EMT. As a means of accomplishing this, we used gene expression data
obtained from tumor and normal tissue biopsies in conjunction with defined gene signatures,
called metagenes, which are indicative of immune infiltration, immune polarization, and
common cancer processes, to infer relationships among these processes via Bayesian
networking. We used data from the invasive breast cancer arm of the TCGA to generate directed
acyclic graphs and used model averaging to establish confidence in the network topology. As a
form of external validation, we found that similar network structures were observed in other
cancers in a manner consistent with the size and diversity of the underlying datasets. In
summary, we have outlined a novel method of identifying areas of local crosstalk between
different cells within the tumor microenvironment using microarray data and prior knowledge of
gene signatures.
As the overall objective was to identify relationships among biological processes
associated with tissue homeostasis and immune-mediated control of multicellular tissues, the
inferred networks identified some interesting crosstalk among these processes. In particular, we
found that an increase in proliferation tended to coincide with increases in cell-mediated immune
responses that promote cancer destruction while EMT increases tended to coincide with
increases in cell-mediated immune responses that either did not kill the cancer or which would
help promote tumor tolerance. For example, in the lung cancer and glioblastoma multiform
datasets increased proliferation led to increases in M1 polarized macrophages, the same
relationship, but in the opposite direction, was identified in the colorectal adenocarcinoma
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dataset. Proliferation was also found to be associated with increases in Th1 cells in colorectal
and breast cancer data sets and with increases in M1 macrophage polarization and natural killer
cell infiltration in glioblastoma multiform. A type I cell-mediated immune response is generally
considered to be the response that has a positive overall impact on cancer survival,45 as it uses
Th1 polarized CD4 T lymphocytes, CD8 T lymphocytes48 and natural killer49 cells as effector
cells to help destroy the cancer. At the same time, increased EMT activity was associated with
increases in M2 polarization in the lung and breast cancer and appeared to be driven by decrease
in natural killer cells in glioblastoma multiform. Of all the cancers analyzed, glioblastoma
multiform was the most divergent. However, this could be simply due to the fact that these
interactions are occurring in an immune-privileged area, with the underlying immune processes
being different that what would be observed in a non-privileged area.
These networks provided a topology and directionality of the intracellular networks at
work in a tumor microenvironment. However, certain aspects of the directionality remain
uncertain. From this study, we had reversed directionality with regards to macrophage
polarization and EMT if the analysis was performed with either the whole breast cancer dataset
or just the malignant samples, which begs the question which model most closely reflects what
occurs within the patient. While the relationship between macrophage polarization and EMT
had not been reported before in breast cancer, similar relationships have been observed in other
forms of cancer, for instance, M2 macrophages are the most common polarization for cancer
associated macrophages50 and promote EMT in vitro51. In melanoma, tumor cells induce
immune-suppression when they undergo EMT52. Alternatively, M2 polarized macrophages have
been shown to induce EMT in certain forms of pancreatic cancer53. Also, feedback loops are a
common motif in biological systems, but are necessarily removed in the directed acyclic graphs
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used in our analysis. This would result in the generation of overly simplistic models – for
example, a positive feedback loop would be interpreted as a straight forward causal relationship.
It is also important to remember the assumptions that are used in these analyses. One of
the larger assumptions is that we can replicate temporal cancer progression using samples from
different cancer biopsies and that cancer follows a single course. The temporal aspect of the data
is limited partially by the fact the biopsies are all taken at diagnosis before treatments has begun.
As such, we do have access to information from more advanced tumors. Also, while we have
tumor biopsies and matched normal biopsies, we do not have any data on intermediate data
between the two, and thus are missing part of the progression. Finally, we needed to assume that
there is a common cancer progression, which, as more data is acquired, may not be the case.
Despite these limitations, these networks do give us an understanding of what
relationships are occurring in human cancer progression. This can be used to help identify and
verify model systems that more closely mimic human disease progression, resulting in the
selection of more relevant models. For example, longitudinal studies using mouse models that
mimic the metagene signatures associated with oncogenesis may help inform ambiguities in our
causal networks as well as serve as a relevant model for testing new treatments. Furthermore,
these models can be used to identify instances of feedback loops. As the amount of available
data increases, it will become possible to create networks for different subsets of cancer
progression, which in turn could help in the identification of model systems that better replicate
certain forms of cancer progression.
One particular strength of this approach is the versatility offered by the use of metagenes.
Since the generation of a metagene only requires that the relevant cells be in the biopsy and an
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accepted list of genes that are differentially expressed by the cells of interest, it is possible to
analyze the relationship between a wide variety of processes. Furthermore, it would also be
possible to include other, global measurements as well as analysis of distal tissue, allowing for
the generation of more systemic models. In summary, we have used an existing technique in a
novel method to observe changes in intercellular relationships using data obtained as part of the
Cancer Genome Atlas. This technique can be used to help identify more relevant disease models
and can be applied to a wide range of more complicated diseases that engulf tissues, complicated
processes associated with tissue development, and regenerative medicine.
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Supplemental Table 1: Directionality and confidence of invasive breast cancer data,

Whole Data Set

Cancer Only

Parent

Child

P-value

Relationship

Parent

Child

P-value

Relationship

pM1
MPhi
Tcell
pTH1
pTh2
pTreg
pM1
pM2
EMT
CD4
Proliferation
Proliferation
pM1
pTreg
Tcell
pTH1
EMT
pTH1
EMT

pM2
Tcell
NK
pTh2
pTh17
pTh2
Tcell
Tcell
MPhi
CD8
pTH1
pM2
Proliferation
pTh17
CD4
NK
pM2
pTh17
pM1

0
8.20E-104
3.65E-46
1.86E-42
1.67E-36
6.26E-35
1.32E-29
1.32E-29
5.43E-22
3.31E-20
3.14E-17
7.38E-16
7.00E-15
5.08E-13
2.16E-06
3.21E-06
5.07E-05
6.43E-05
0.000585

+
+
+
+
+
+
+
+
+
+
-

pM1
MPhi
Tcell
pTH1
pTh2
pTreg
pM1
pM2
MPhi

pM2
Tcell
NK
pTh2
pTh17
pTh2
Tcell
Tcell
EMT

0
6.75E-103
1.57E-45
3.67E-38
1.04E-31
3.02E-32
7.33E-20
7.33E-20
1.55E-23

+
+
+
+
+

pTH1

Proliferation

1.00E-20

+
-

pTreg

pTh17

4.06E-12

-

pTH1
pM2
pTH1
pM1
Tcell

NK
EMT
pTh17
EMT
CD8

2.45E-08
4.08E-14
5.25E-05
4.08E-14
0.003424

+
+

Directionality and confidence of connection as generated from 100,000 bootstrap resamplings of the calculated
metagene values for breast cancer. The left graph represents the whole dataset, and the right graph represen3ts
the cancer samples alone. Relationship signifies whether the two had a positive or negative correlation.
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Supplemental Table 2: Directionality and confidence of colon adenocarcinoma

Whole Data Set

Cancer Only

Parent

Child

P-value

Relationship

Parent

Child

P-value

Relationship

pM1
Tcell
NK
CD8
pTH1
pTreg
pTH1
pTreg
pTh17
pM1
Proliferation
pM1
pM2

pM2
MPhi
Tcell
CD4
pTh17
pTh17
pTh2
pTh2
NK
Proliferation
pM2
MPhi
MPhi

0
5.13E-44
9.10E-30
1.39E-15
2.36E-15
9.68E-15
5.74E-13
8.13E-13
1.84E-10
2.35E-05
2.48E-05
4.78E-05
4.78E-05

+
+
+
+
+

pM1
Tcell
NK
CD4
pTh17
pTreg
pTh2
pTh2

pM2
MPhi
Tcell
CD8
pTH1
pTh17
pTH1
pTreg

0
6.41E-38
1.80E-23
2.17E-26
1.60E-15
1.89E-05
9.55E-14
0.000173

+
+
+
-

Proliferation 0.000149
pM1
0.000238
pM2
0.00025

+

pTh17
EMT
EMT

Directionality and confidence of connection as generated from 100,000 bootstrap resamplings of the calculated
metagene values for colon adenocarcinoma. The left graph represents the whole dataset, and the right graph
represents the cancer samples alone. Relationship signifies whether the two had a positive or negative
correlation.
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Supplemental Table 3: Directionality and confidence of lung cancer

Parent

Child

P-value

pM1
Tcell
NK
pTh17
pTh2
EMT
pTh2
pTh17
EMT
EMT
pTH1
NK

pM2
MPhi
Tcell
pTreg
pTreg
Tcell
pTH1
pTH1
pM1
pM2
Proliferation
pTH1

0
4.63E-38
2.59E-27
3.11E-18
5.06E-17
9.89E-13
9.23E-06
0.000663
0.001161
0.001205
0.00871
0.017097

Relationship
+
+
+
+
+

Directionality and confidence of connection as generated from 100,000 bootstrap resamplings of the calculated
metagene values for lung cancer. Relationship signifies whether the two had a positive or negative correlation.
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Supplemental Table 4: Directionality and confidence of glioblastoma multiform
Whole Data Set

Cancer Only

Parent

Child

P-value

Relationship

Parent

pM1
pTH1
pTreg
Tcell
Tcell
MPhi
pTh17
pTH1
Tcell
pM1
pM2
pTreg
MPhi
pTH1
pTh17

pM2
pTh17
pTh17
EMT
MPhi
pTH1
pTh2
pTreg
pTreg
MPhi
MPhi
pTh2
Proliferation
pTh2
Proliferation
EMT
NK
Proliferation
Proliferation

0
3.00E-61
3.16E-47
3.39E-43
3.11E-33
6.01E-29
1.76E-28
2.00E-27
5.65E-25
7.37E-22
7.37E-22
3.92E-17
2.42E-13
2.81E-13
3.05E-13
4.45E-12
9.80E-06
0.000487
0.000487

+
+
+
+
+
+
+
+
+
-

pM1
pTH1
pTreg
Tcell
Tcell
MPhi
pTh17
pTH1
Tcell
pM1
pM2
pTreg
MPhi
pTH1

NK
Proliferation

pM1
pM2

Child

P-value

Relationship

pM2
pTh17
pTh17
EMT
MPhi
pTH1
pTh2
pTreg
pTreg
MPhi
MPhi
pTh2
Proliferation
pTh2

0
3.04E-59
7.60E-46
9.73E-49
2.51E-34
4.72E-27
4.03E-29
2.42E-26
6.74E-24
1.32E-23
1.32E-23
5.65E-16
2.15E-12
1.89E-12

+
+
+
+
+
+
+
-

NK
EMT
Proliferation
NK
pM2
Proliferation
pM1
Proliferation
pM2
EMT
pM1
EMT
pTreg
CD4

2.34E-12
5.24E-07
0.000109
0.000109
5.89E-09
5.89E-09
0.022077

+
+
+
+

Directionality and confidence of connection as generated from 100,000 bootstrap resamplings of the calculated
metagene values for colon adenocarcinoma. The left graph represents the whole dataset, and the right graph
represents the cancer samples alone. Relationship signifies whether the two had a positive or negative
correlation.
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Supplemental Table 5: Directionality and confidence of invasive breast cancer data, 75% of dataset

Whole Data Set

Cancer Only

Parent

Child

P value

Relationship

Parent

Child

P value

Relationship

pM1
MPhi
Tcell
pTH1
pTh17
pM2
pM1
CD4
pTreg
pTh17
EMT
Proliferation
Proliferation
Proliferation
pTH1
Tcell
EMT
EMT

pM2
Tcell
NK
pTh17
pTh2
Tcell
Tcell
CD8
pTh2
pTreg
MPhi
pTH1
pM1
pM2
pTh2
CD4
pM1
pM2

0
2.03E-81
3.82E-56
8.90E-30
2.44E-28
3.53E-25
3.53E-25
4.31E-19
1.54E-14
2.28E-14
3.01E-14
1.62E-13
4.07E-12
4.30E-12
3.83E-09
1.81E-05
0.00047
0.000477

+
+
+
+
+
+
+
+
+
+

pM1
MPhi
Tcell
pTH1
pTh17
pM2
pM1

pM2
Tcell
NK
pTh17
pTh2
Tcell
Tcell

0
1.17E-89
3.85E-61
2.68E-52
1.04E-28
1.15E-17
1.15E-17

+
+
+
+

pTreg
pTreg
MPhi
pTH1

pTh2
pTh17
EMT
Proliferation

9.38E-13
4.10E-41
7.95E-23
1.93E-17

+
+

pTH1

pTh2

1.89E-10

-

pM1
pM2
CD8
Tcell

EMT
EMT
Proliferation
CD8

9.94E-12
9.94E-12
0.001114
0.004646

+
+
+

Directionality and confidence of connection as generated from 100,000 bootstrap resamplings of the calculated
metagene values for 75% of the invasive breast cancer dataset. The left graph represents the whole dataset,
and the right graph represents the cancer samples alone. Relationship signifies whether the two had a positive
or negative correlation.
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Supplemental Table 6: Directionality and confidence of invasive breast cancer data, 50% of dataset

Whole Data Set
Parent
pM1
CD8
MPhi
Tcell
pTh17
EMT
pTH1
pTH1
Proliferation
Proliferation
pTh2
pM1
pM2
Tcell
EMT
EMT
pTh2

Child
pM2
CD4
Tcell
NK
pTreg
MPhi
pTh2
Proliferation
pM1
pM2
pTreg
Tcell
Tcell
CD4
pM1
pM2
pTh17

P value
0
0
1.62E-56
9.20E-43
8.76E-14
9.60E-13
2.52E-11
2.86E-11
1.11E-10
1.19E-10
1.32E-10
5.48E-10
5.48E-10
3.80E-07
0.001047
0.001068
0.007238

Cancer Only
Relationship
+
+
+
+
+
+
+
+
+
-

Parent
pM1

Child
pM2

P value
0

Relationship
-

MPhi
Tcell
pTh17
MPhi
pTh2

Tcell
NK
pTreg
EMT
pTH1

8.70E-60
1.35E-23
1.74E-17
1.91E-19
1.02E-25

+
+
+
-

pTh2
pM1
pM2

pTreg
Tcell
Tcell

3.81E-14
9.34E-12
9.34E-12

+
-

pM1
pM2

EMT
EMT

4.95E-08
4.95E-08

+

pTh17
pTH1
pTH1
CD8
Tcell

pTH1
Proliferation
NK
Proliferation
CD8

4.71E-34
1.46E-10
2.80E-05
0.000486
0.032026

+
+
+
+

Directionality and confidence of connection as generated from 100,000 bootstrap resamplings of the
calculated metagene values for 50% of the invasive breast cancer dataset. The left graph represents the whole
dataset, and the right graph represents the cancer samples alone. Relationship signifies whether the two had a
positive or negative correlation.
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Supplemental Table 7: Directionality and confidence of invasive breast cancer data, 25% of dataset
Whole Data Set
Parent
pM1
MPhi
Tcell
pTh17
pTh2
pTh2
pTh17
MPhi
pM2
pM1
pTH1
Proliferation
Proliferation
Tcell
Tcell

Child
pM2
Tcell
NK
pTH1
pTH1
pTreg
pTreg
EMT
Tcell
Tcell
Proliferation
pM1
pM2
CD8
CD4

P value
0
2.31E-26
3.31E-19
5.80E-14
6.94E-13
2.70E-09
6.65E-09
1.01E-08
2.44E-08
2.44E-08
2.80E-05
0.000235
0.000247
0.000594
0.011028

Cancer Only
Relationship
+
+
+
+
+
+
+
+

Parent
pM1
MPhi
Tcell
pTH1

Child
pM2
Tcell
NK
pTh17

P value Relationship
0
1.96E-26
+
3.39E-20
+
7.06E-09
-

pTh2
pTh17

pTreg
pTreg

1.09E-08
7.28E-10

-

pTH1

Proliferation

2.36E-06

+

CD8
EMT
pM1
pM2

CD4
MPhi
EMT
EMT

1.42E-30
2.23E-05
0.000132
0.000132

+
+
+

Directionality and confidence of connection as generated from 100,000 bootstrap resamplings of the calculated
metagene values for 25% of the invasive breast cancer dataset. The left graph represents the whole dataset,
and the right graph represents the cancer samples alone. Relationship signifies whether the two had a positive
or negative correlation.
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Supplemental Table 8: Breast Cancer Summary Data

Gender
Age at Diagnosis
Metastasis Code
Cancer Stage I
Cancer Stage II
Cancer Stage III
Cancer Stage IV
Cancer Stage X

Whole Dataset
F = 572, M = 6
57.88
M0 = 374, M1 = 10, MX =
10, Null = 139
N = 42, A = 23, B = 2
N = 0, A = 136, B = 84
N = 0, A = 60, B = 12, C =
14
8
11

Group 1
F = 304, M = 4
57.57
M0 = 224, M1 = 6, MX =
6, Null = 70
N = 26, A = 13, B = 1
N = 0, A = 76, B = 50
N = 0, A = 42, B =5, C =
8
6
9

Group 2
F = 219, M = 2
58.34
M0 = 148, M1 = 4, MX =
4, Null=69
N = 15, A = 10, B = 1
N = 0, A = 59, B = 34
N = 0, A = 18, B = 5, C =
6
2
2

Table represents all data with regards to gender distribution, age at diagnosis, metastasis code and cancer stage
for whole invasive breast cancer dataset as well as cancer group 1 and group 2 available when data was
initially downloaded.
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Supplemental Figure 1: The cancer groups differ in their expression of the EMT metagene, proliferation
metagene, and macrophage polarizations. The distribution of the T cell metagene (a), the macrophage
metagene (b), the NK metagene (c), pTh1 metagene (d), pTh17 metagene (e), pTh2 metagene (f), the pTreg
metagene (g), the pM1 macrophage metagene (h), the EMT metagene (i), and the proliferation metagene (j)
were generated and separated by grouping, with black representing cancer group 1 and yellow representing
cancer group 2. * represents a p-value of less than .01.

51

Supplemental Figure 2: Multidimensional Scaling as principal coordinate analysis was preformed. Genes
were color coded based on metagene grouping, EMT (black), Proliferation (grey), T cell infiltration (green),
NK cell infiltration (red), Macrophage Infiltration (orange), T cell polarization (yellow), and Macrophage
polarization (blue). Scaling was performed using the cmdscale() function.
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